Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study.
Dahm-Kähler P, Holmberg E, Holtenman M, Rådestad AF, Borgfeldt C, Hjerpe E, Marcickiewicz J, Bjurberg M, Tholander B, Hellman K, Kjølhede P, Högberg T, Rosenberg P, Åvall-Lundqvist E, Stålberg K. Dahm-Kähler P, et al. Among authors: hjerpe e. Gynecol Oncol. 2021 Apr;161(1):244-250. doi: 10.1016/j.ygyno.2021.01.012. Epub 2021 Feb 10. Gynecol Oncol. 2021. PMID: 33581846
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) study.
Hjerpe E, Staf C, Dahm-Kähler P, Stålberg K, Bjurberg M, Holmberg E, Borgfeldt C, Tholander B, Hellman K, Kjølhede P, Högberg T, Rosenberg P, Åvall-Lundqvist E. Hjerpe E, et al. Acta Oncol. 2018 Mar;57(3):331-337. doi: 10.1080/0284186X.2017.1400691. Epub 2017 Nov 12. Acta Oncol. 2018. PMID: 29130381
Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
Stålberg K, Bjurberg M, Borgfeldt C, Carlson J, Dahm-Kähler P, Flöter-Rådestad A, Hellman K, Hjerpe E, Holmberg E, Kjølhede P, Marcickiewicz J, Rosenberg P, Tholander B, Åvall-Lundqvist E, Högberg T. Stålberg K, et al. Among authors: hjerpe e. Acta Oncol. 2019 Nov;58(11):1628-1633. doi: 10.1080/0284186X.2019.1643036. Epub 2019 Aug 2. Acta Oncol. 2019. PMID: 31373248
Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group Study.
Bjurberg M, Holmberg E, Borgfeldt C, Flöter-Rådestad A, Dahm-Kähler P, Hjerpe E, Högberg T, Kjølhede P, Marcickiewicz J, Rosenberg P, Stålberg K, Tholander B, Hellman K, Åvall-Lundqvist E. Bjurberg M, et al. Among authors: hjerpe e. Gynecol Oncol. 2019 Nov;155(2):229-236. doi: 10.1016/j.ygyno.2019.08.022. Epub 2019 Aug 30. Gynecol Oncol. 2019. PMID: 31477283
Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma: A population-based SweGCG study.
Hellman K, Holmberg E, Bjurberg M, Borgfeldt C, Dahm-Kähler P, Flöter Rådestad A, Hjerpe E, Högberg T, Marcickiewicz J, Rosenberg P, Stålberg K, Tholander B, Kjølhede P, Åvall-Lundqvist E. Hellman K, et al. Among authors: hjerpe e. Gynecol Oncol. 2020 Dec;159(3):663-671. doi: 10.1016/j.ygyno.2020.09.027. Epub 2020 Sep 26. Gynecol Oncol. 2020. PMID: 32988623
Survival in endometrial cancer in relation to minimally invasive surgery or open surgery - a Swedish Gynecologic Cancer Group (SweGCG) study.
Borgfeldt C, Holmberg E, Marcickiewicz J, Stålberg K, Tholander B, Lundqvist EÅ, Flöter-Rådestad A, Bjurberg M, Dahm-Kähler P, Hellman K, Hjerpe E, Kjölhede P, Rosenberg P, Högberg T. Borgfeldt C, et al. Among authors: hjerpe e. BMC Cancer. 2021 Jun 2;21(1):658. doi: 10.1186/s12885-021-08289-3. BMC Cancer. 2021. PMID: 34078319 Free PMC article.
HSP60 predicts survival in advanced serous ovarian cancer.
Hjerpe E, Egyhazi S, Carlson J, Stolt MF, Schedvins K, Johansson H, Shoshan M, Avall-Lundqvist E. Hjerpe E, et al. Int J Gynecol Cancer. 2013 Mar;23(3):448-55. doi: 10.1097/IGC.0b013e318284308b. Int J Gynecol Cancer. 2013. PMID: 23429486
23 results